Literature DB >> 31700906

TSPAN8 serves as a prognostic marker involving Akt/MAPK pathway in nasopharyngeal carcinoma.

Xiao Lin1,2, Zhuofei Bi1,3, Qian Hu4, Qingjian Li1,5, Jieqiong Liu1,2, Man-Li Luo1,6, Yanqun Xiang7, Herui Yao1,2,5.   

Abstract

BACKGROUND: Nasopharyngeal carcinoma (NPC) is a common epithelial carcinoma with high occurrence and metastatic rates in Southern China. To date, the molecular mechanisms of metastasis for NPC remains unclear. The aim of this study was to discover the underlying mechanism of NPC and to elucidate novel genes that may play important roles in NPC progression and metastasis.
METHODS: We carry out mRNA expression profiling, Arraystar Human mRNA Expression Profiling Service Report based on polymerase chain reaction (PCR) using four pairs of tumor tissues and their corresponding benign adjacent tissues from NPC patients.
RESULTS: We found that 1,787 genes were differentially expressed, among them, 8 genes were identified as highly upregulated in NPC patients. Within these 8 genes, only TSPAN8 was consistently over-expressed in poorly differentiated CNE2 cell line and highly-metastatic subclone S18 cell line. TSPAN8 mRNA and protein levels were increased in primary carcinoma tissues compared to their corresponding adjacent benign tissues. Knockdown of TSPAN8 by siRNA resulted in inhibition of NPC cell migration and invasion, while overexpression of TSPAN8 promoted NPC cell migration, invasion and proliferation. To explore the potential metastasis pathway mechanism for NPC, TSPAN8 were silenced in CNE2 cell. From the Tumor Metastasis Pathway Finder PCR array, knockdown of TSPAN8 led to the down-regulation of IL-1β, which showed the most down-regulation among identified genes. IL-1β is a regulating factor of the Akt/MAPK pathway, which is involved in the cancer cell migration regulation. Furthermore, the down-regulation of TSPAN8 in CNE2 cell was associated with inhibition of the Akt/MAPK pathway. Immunohistochemistry (IHC) indicated that TSPAN8 level was increased in NPC tumors, which was associated with shorter overall survival and metastasis free survival (MFS).
CONCLUSIONS: The data indicated that TSPAN8 acting as a tumor migration marker and may be a prognostic factor or therapeutic target for NPC. 2019 Annals of Translational Medicine. All rights reserved.

Entities:  

Keywords:  Akt/MAPK signaling pathway; TSPAN8; metastasis; nasopharyngeal carcinoma (NPC)

Year:  2019        PMID: 31700906      PMCID: PMC6803210          DOI: 10.21037/atm.2019.08.02

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  46 in total

Review 1.  Functional domains in tetraspanin proteins.

Authors:  Christopher S Stipp; Tatiana V Kolesnikova; Martin E Hemler
Journal:  Trends Biochem Sci       Date:  2003-02       Impact factor: 13.807

2.  Deletion of tetraspanin Cd151 results in decreased pathologic angiogenesis in vivo and in vitro.

Authors:  Yoshito Takeda; Alexander R Kazarov; Catherine E Butterfield; Benjamin D Hopkins; Laura E Benjamin; Arja Kaipainen; Martin E Hemler
Journal:  Blood       Date:  2006-10-05       Impact factor: 22.113

3.  TSPAN8, identified by Escherichia coli ampicillin secretion trap, is associated with cell growth and invasion in gastric cancer.

Authors:  Katsuhiro Anami; Naohide Oue; Tsuyoshi Noguchi; Naoya Sakamoto; Kazuhiro Sentani; Tetsutaro Hayashi; Yutaka Naito; Htoo Zarni Oo; Wataru Yasui
Journal:  Gastric Cancer       Date:  2015-02-25       Impact factor: 7.370

4.  AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas.

Authors:  J Q Cheng; A K Godwin; A Bellacosa; T Taguchi; T F Franke; T C Hamilton; P N Tsichlis; J R Testa
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

5.  Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas.

Authors:  A Bellacosa; D de Feo; A K Godwin; D W Bell; J Q Cheng; D A Altomare; M Wan; L Dubeau; G Scambia; V Masciullo; G Ferrandina; P Benedetti Panici; S Mancuso; G Neri; J R Testa
Journal:  Int J Cancer       Date:  1995-08-22       Impact factor: 7.396

6.  The association of the tetraspanin D6.1A with the alpha6beta4 integrin supports cell motility and liver metastasis formation.

Authors:  Mikael Herlevsen; Dirk-Steffen Schmidt; Kaoru Miyazaki; Margot Zöller
Journal:  J Cell Sci       Date:  2003-09-16       Impact factor: 5.285

7.  Preparing the "soil": the primary tumor induces vasculature reorganization in the sentinel lymph node before the arrival of metastatic cancer cells.

Authors:  Chao-Nan Qian; Bree Berghuis; Galia Tsarfaty; MaryBeth Bruch; Eric J Kort; Jon Ditlev; Ilan Tsarfaty; Eric Hudson; David G Jackson; David Petillo; Jindong Chen; James H Resau; Bin Tean Teh
Journal:  Cancer Res       Date:  2006-10-23       Impact factor: 12.701

8.  Tetraspanin CO-029 inhibits colorectal cancer cell movement by deregulating cell-matrix and cell-cell adhesions.

Authors:  Qiusha Guo; Bing Xia; Feng Zhang; Mekel M Richardson; Minghao Li; Julian S Zhang; Feng Chen; Xin A Zhang
Journal:  PLoS One       Date:  2012-06-05       Impact factor: 3.240

9.  Cytochrome P450 2E1 polymorphism and nasopharyngeal carcinoma development in Thailand: a correlative study.

Authors:  N Kongruttanachok; S Sukdikul; S Setavarin; V Kerekhjanarong; P Supiyaphun; N Voravud; Y Poovorawan; A Mutirangura
Journal:  BMC Cancer       Date:  2001-05-25       Impact factor: 4.430

10.  Loss of CX3CR1 increases accumulation of inflammatory monocytes and promotes gliomagenesis.

Authors:  Xi Feng; Frank Szulzewsky; Alexan Yerevanian; Zhihong Chen; David Heinzmann; Rikke Darling Rasmussen; Virginia Alvarez-Garcia; Yeonghwan Kim; Bingcheng Wang; Ilaria Tamagno; Hao Zhou; Xiaoxia Li; Helmut Kettenmann; Richard M Ransohoff; Dolores Hambardzumyan
Journal:  Oncotarget       Date:  2015-06-20
View more
  5 in total

1.  Deeper insights into long-term survival heterogeneity of pancreatic ductal adenocarcinoma (PDAC) patients using integrative individual- and group-level transcriptome network analyses.

Authors:  Archana Bhardwaj; Claire Josse; Daniel Van Daele; Christophe Poulet; Marcela Chavez; Ingrid Struman; Kristel Van Steen
Journal:  Sci Rep       Date:  2022-06-30       Impact factor: 4.996

Review 2.  TSPAN8 as a Novel Emerging Therapeutic Target in Cancer for Monoclonal Antibody Therapy.

Authors:  Kyun Heo; Sukmook Lee
Journal:  Biomolecules       Date:  2020-03-03

3.  miR-543 regulates high glucose-induced fibrosis and autophagy in diabetic nephropathy by targeting TSPAN8.

Authors:  Langen Zhuang; Xiaoxu Ge; Xiaolei Hu; Qingqing Yang; Xiaoyan Pei; Guoxi Jin
Journal:  BMC Nephrol       Date:  2022-03-04       Impact factor: 2.388

4.  The clinical prognostic value of PD-L1 after concurrent chemoradiotherapy in Chinese nasopharyngeal carcinoma patients.

Authors:  Guoxian Long; Xiaoyu Li; Lin Yang; Jing Zhao; Xiang Lu; Heng Wang; Jia Song; Qi Mei; Guangyuan Hu
Journal:  Ann Transl Med       Date:  2021-11

5.  TSPAN8 and distant metastasis of nasopharyngeal carcinoma cells.

Authors:  Changqing Xie; Nicole A McGrath
Journal:  Ann Transl Med       Date:  2020-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.